dc.contributor.author | Abdul Momin, MHF | en_US |
dc.contributor.author | Liakopoulos, A | en_US |
dc.contributor.author | Wareham, DW | en_US |
dc.date.accessioned | 2017-07-25T14:15:53Z | |
dc.date.available | 2017-06-15 | en_US |
dc.date.issued | 2017-07-06 | en_US |
dc.date.submitted | 2017-07-24T16:57:21.027Z | |
dc.identifier.issn | 2169-8287 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/24972 | |
dc.description.abstract | Carbapenem-resistant Klebsiella pneumoniae infection is a rising public health threat due to limited therapeutic options. Here, we report the genome sequence of a multidrug-resistant K. pneumoniae sequence type 231 (ST231) strain associated with an outbreak of infections in an intensive care unit that carries a unique complement of resistance determinants. | en_US |
dc.description.sponsorship | This study forms part of M. H. F. Abdul Momin’s Ph.D. project, financially supported
by the Brunei Darussalam Government in-service training scheme. | en_US |
dc.language | eng | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Genome Announc | en_US |
dc.rights | CC BY 4.0 | |
dc.title | Draft Genome Sequence of a Multidrug-Resistant Sequence Type 231 Outbreak-Associated Clone of Klebsiella pneumoniae, KP41-2015, Producing OXA-232 Carbapenemase. | en_US |
dc.type | Article | |
dc.rights.holder | © 2017 Abdul Momin et al. | |
dc.identifier.doi | 10.1128/genomeA.00604-17 | en_US |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/28684582 | en_US |
pubs.issue | 27 | en_US |
pubs.notes | No embargo | en_US |
pubs.publication-status | Published online | en_US |
pubs.volume | 5 | en_US |